
Dr. Reddy's Laboratories reported its Q3 earnings for FY25, revealing a net profit of ₹1,413.3 crore, which represents a year-over-year increase of 2.5% from ₹1,379 crore. The company's revenue rose by 15.8% to ₹8,381 crore, compared to ₹7,237 crore in the same quarter last year. The profit figure fell short of the CNBC-TV18 poll estimate of ₹1,501.4 crore. The operating margin was noted at 27.5%, down from 29.3% in the previous year.
#EarningsWithMC | Dr Reddy's Labs Q3 Results: Net profit up 2.5% at Rs 1,413 crore, beats estimate⚡️ More details here 👇 https://t.co/EGMTTjMVtD #Q3Results #Q3FY25 #Earnings
Q3FY25 Results Update: Dr. Reddy's Laboratories Ltd #stockmarketsindia #Q3FY25 #Q3FY2025 #Q3FY25Results #Q3Results #Q3 #StockMarketindia #DRREDDY #DrReddys https://t.co/GNwgk4C3OZ
Dr Reddy announces Q3 earnings --Net Profit Up 2.5% At ₹1,413 Cr Vs ₹1379 Cr (YoY) --Revenue Up 15.9% At ₹8,357 Cr Vs ₹7,215 Cr (YoY) --Margin At 27.5% Vs ₹29.3% Cr (YoY)
